中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2010年
3期
156-158
,共3页
宋亮%王洲%刘相燕%陈钢%刘凡英
宋亮%王洲%劉相燕%陳鋼%劉凡英
송량%왕주%류상연%진강%류범영
食管肿瘤%放疗%淋巴转移%外科手术%肿瘤复发
食管腫瘤%放療%淋巴轉移%外科手術%腫瘤複髮
식관종류%방료%림파전이%외과수술%종류복발
Esophageal neoplasm%Radiotherapy%Lymphatic metastasis%Surgical procedure%Neoplasm recurrence
目的:探讨Ivor-Lewis手术后辅助放疗对胸中段食管癌淋巴结转移性复发的预防作用,旨在于提高食管癌手术的局部控制率.方法:回顾1999年6月~2004年6月间山东大学附属省立医院胸外科采用改良Ivor-Lewis手术并胸、腹二野淋巴结清扫治疗366例胸中段食管鳞癌患者的完整临床资料,应用SPSS 13.0软件包建立数据库,并进行统计分析,Kaplan-meier法计算复发率;log-rank检验比较复发率差异;Cox回归分析判定手术后淋巴结转移的独立危险因素.结果:术后3年内,366例患者中105例(28.7%)发生淋巴结转移,占全部复发患者的52.2%(105/201).181例辅助放疗惠者中,37例发生淋巴结转移(20.4%),与单纯化疗和未经系统性辅助治疗患者相比,淋巴结转移率显著降低(P<0.05).103例单纯化疗患者中,33例发生淋巴结转移(32.0%),低于未经手术后辅助治疗患者的淋巴结转移率,但差异无统计学意义(P=0.17).Cox回归分析结果显示:肿瘤的T分类、淋巴结转移和手术后辅助放疗是术后淋巴结转移的独立预后因素.结论:改良Ivor-Lewis手术无严重的手术后并发症.术后辅助放疗患者的局部淋巴结转移率显著降低.肿瘤的T分类、淋巴结转移和手术后辅助放疗是术后淋巴结转移的独立预后因素.Ivor-Lewis手术辅助术后放疗,是对胸中段食管鳞癌实现预防淋巴结转移性复发的有效候选方法之一.
目的:探討Ivor-Lewis手術後輔助放療對胸中段食管癌淋巴結轉移性複髮的預防作用,旨在于提高食管癌手術的跼部控製率.方法:迴顧1999年6月~2004年6月間山東大學附屬省立醫院胸外科採用改良Ivor-Lewis手術併胸、腹二野淋巴結清掃治療366例胸中段食管鱗癌患者的完整臨床資料,應用SPSS 13.0軟件包建立數據庫,併進行統計分析,Kaplan-meier法計算複髮率;log-rank檢驗比較複髮率差異;Cox迴歸分析判定手術後淋巴結轉移的獨立危險因素.結果:術後3年內,366例患者中105例(28.7%)髮生淋巴結轉移,佔全部複髮患者的52.2%(105/201).181例輔助放療惠者中,37例髮生淋巴結轉移(20.4%),與單純化療和未經繫統性輔助治療患者相比,淋巴結轉移率顯著降低(P<0.05).103例單純化療患者中,33例髮生淋巴結轉移(32.0%),低于未經手術後輔助治療患者的淋巴結轉移率,但差異無統計學意義(P=0.17).Cox迴歸分析結果顯示:腫瘤的T分類、淋巴結轉移和手術後輔助放療是術後淋巴結轉移的獨立預後因素.結論:改良Ivor-Lewis手術無嚴重的手術後併髮癥.術後輔助放療患者的跼部淋巴結轉移率顯著降低.腫瘤的T分類、淋巴結轉移和手術後輔助放療是術後淋巴結轉移的獨立預後因素.Ivor-Lewis手術輔助術後放療,是對胸中段食管鱗癌實現預防淋巴結轉移性複髮的有效候選方法之一.
목적:탐토Ivor-Lewis수술후보조방료대흉중단식관암림파결전이성복발적예방작용,지재우제고식관암수술적국부공제솔.방법:회고1999년6월~2004년6월간산동대학부속성립의원흉외과채용개량Ivor-Lewis수술병흉、복이야림파결청소치료366례흉중단식관린암환자적완정림상자료,응용SPSS 13.0연건포건립수거고,병진행통계분석,Kaplan-meier법계산복발솔;log-rank검험비교복발솔차이;Cox회귀분석판정수술후림파결전이적독립위험인소.결과:술후3년내,366례환자중105례(28.7%)발생림파결전이,점전부복발환자적52.2%(105/201).181례보조방료혜자중,37례발생림파결전이(20.4%),여단순화료화미경계통성보조치료환자상비,림파결전이솔현저강저(P<0.05).103례단순화료환자중,33례발생림파결전이(32.0%),저우미경수술후보조치료환자적림파결전이솔,단차이무통계학의의(P=0.17).Cox회귀분석결과현시:종류적T분류、림파결전이화수술후보조방료시술후림파결전이적독립예후인소.결론:개량Ivor-Lewis수술무엄중적수술후병발증.술후보조방료환자적국부림파결전이솔현저강저.종류적T분류、림파결전이화수술후보조방료시술후림파결전이적독립예후인소.Ivor-Lewis수술보조술후방료,시대흉중단식관린암실현예방림파결전이성복발적유효후선방법지일.
Objective: To explore the effect of radiotherapy on preventing the recurrence of lymph node metastasis of esophageal cancer after Ivor-Lewis esophagectomy. Methods: Three hundred and sixty-six pa-tients with middle third squamous cell carcinoma of the esophagus were enrolled in this study. All patients un-derwent Ivor-Lewis esophagectomy with two-field lymph node dissection in our hospital between June 1999 and June 2004. All statistical analyses were performed with SPSS 13.0 statistical software. Kaplan-Meier method was performed to calculate the relapse rate. Log-rank test was performed to compare the relapse rate. Cox regression analysis was performed to identify independent prognostic factors for postoperative lymph node metastasis. Results: Of the 366 cases, lymph node metastasis was found in 105 patients (28.5%)within 3 years after surgery, occupying 52.2% (105/201) of total recurrence. Of the 181 patients treated with postoperative radiotherapy, lymph node metastasis was found in 37 patients. The rate of lymph node metasta-sis was 20.4%, significantly lower than that in patients treated with chemotherapy alone and those without sys-temic adjuvant therapy (P<0.05). Chemotherapy was administered in 103 cases and lymph node metastasis was found in 33 patients. The rate of lymph node metastasis was 32.0%, lower than that in patients without systemic adjuvant therapy, but without statistical significance (P=0.17). The results of Cox analysis demon-strated that T stage, lymph node metastasis and postoperative adjuvant radiotherapy were independent prog-nostic factors. Conclusion: Ivor-Lewis esophagectomy for the middle third thoracic esophageal cancer was a safe surgical procedure. Postoperative radiotherapy is helpful for the control of local recurrence. T stage,lymph node metastasis and postoperative adjuvant radiotherapy are independent prognostic factors. Radio-therapy is helpful for preventing the recurrence of lymph node metastasis of esophageal cancer after Ivor-Lew-is esophagectomy.